by admin | Nov 8, 2022 | News
We are proud to be awarded at the 5th Blue Bio Value Accelerator, which included the participation of 18 selected startups from 12 countries. This international cohort focused on innovative solutions aligned with blue economy principles. Organized by Oceano Azul...
by admin | Oct 17, 2022 | News
Exogenus Therapeutics announces that its exclusively licensed patent entitled “USE OF UMBILICAL CORD BLOOD DERIVED EXOSOMES FOR TISSUE REPAIR” has been granted in China and Korea. The patent describes the use of extracellular vesicles secreted by umbilical cord blood...
by admin | Sep 23, 2022 | News
Exogenus Therapeutics was one of the 18 startups selected to take part in the Blue Bio Value Accelerator organized by Oceano Azul Foundation, Calouste Gulbekian Foundation and Maze. The accelerator aims to train and promote international startups working in the blue...
by admin | Sep 20, 2022 | News
Exogenus Therapeutics CEO, Joana Simões Correia, is again an invited speaker at the 4th Exosome Based Therapeutic Development Summit, taking place in Boston, October 4th-6th. Joana’s talk will focus on the importance of EV quality control and on the therapeutic...
by admin | Jul 22, 2022 | News
Labiotech, a Berlin-based digital media company covering biotech, recently published an article highlighting Portuguese success stories, which include Exogenus Therapeutics and other “neighbors” headquartered in Biocant (Cantanhede), such as Immunethep and Biotrend....
by admin | Jun 13, 2022 | News
Joana Correia, Exogenus’s co-founder, CEO and CSO is an invited speaker at the IX BiotechHealth Annual Symposium, organized by i3S and taking place on June 28th 2022. Joana will be taking us on a trip from her days as an academic researcher to founding and...
